Table 1.
Study 1 | Study 2 | |||
---|---|---|---|---|
Bimatoprost 0.03 % | Vehicle | Bimatoprost 0.03 % | Vehicle | |
(n = 88) | (n = 85) | (n = 18) | (n = 18) | |
n (%) | n (%) | n (%) | n (%) | |
Mean age: years (range) | 40.1 (20–68) | 41.4 (20–64) | 46.3 (31–61) | 54.9 (39–74) |
Age distribution | ||||
<45 years | 58 (65.9) | 48 (56.5) | 8 (44.4) | 3 (16.7) |
45–65 years | 29 (33.0) | 37 (43.5) | 10 (55.6) | 12 (66.7) |
>65 years | 1 (1.1) | 0 (0) | 0 (0) | 3 (16.7) |
Gender | ||||
Males | 9 (10.2) | 9 (10.6) | 0 (0) | 0 (0) |
Females | 79 (89.8) | 76 (89.4) | 18 (100) | 18 (100) |
Baseline GEA score | ||||
1 (minimal) | 30 (34.1) | 21 (24.7) | 12 (66.7) | 14 (77.8) |
2 (moderate) | 57 (64.8) | 64 (75.3) | 6 (33.3) | 4 (22.2) |
3 (marked) | 1 (1.1)a | 0 (0) | 0 (0) | 0 (0) |
GEA Global Eyelash Assessment
All the subjects were Japanese
aThe subject was randomized but did not receive treatment